Pentazocine Hydrochloride And Acetaminophen
Product Images NDC 43386-670

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Pentazocine Hydrochloride And Acetaminophen (NDC 43386-670). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Gavis Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fc01cb97-figure-01 (Fc01cb97 Figure 01)

Chemical structure diagram of the active ingredient shown, depicting the atomic and molecular configuration of the compound related to Pentazocine Hydrochloride and Acetaminophen.*

FDA Label Image

Fc01cb97-figure-02 (Fc01cb97 Figure 02)

Chemical structure of acetaminophen shown as a molecular diagram with labeled functional groups including hydroxyl and amide groups attached to a benzene ring.*

FDA Label Image

Fc01cb97-figure-03 (Fc01cb97 Figure 03)

Label for Pentazocine Hydrochloride and Acetaminophen tablets by GAVIS Pharmaceuticals, LLC. The label indicates a strength of 25 mg (base) Pentazocine and 650 mg Acetaminophen per tablet. The package contains 100 tablets and is marked Rx only. Additional label details include storage instructions and manufacturer information in Somerset, NJ.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.